{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:01:37Z","timestamp":1763748097298,"version":"3.41.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01405","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T04:46:15Z","timestamp":1580359575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy"],"prefix":"10.3389","volume":"10","author":[{"given":"Jordi","family":"Gandini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Manto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Charette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2214\/AJR.07.2024","article-title":"Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings","volume":"189","author":"McKinney","year":"2007","journal-title":"Am J Roentgenol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/practneurol-2011-000010","article-title":"The posterior reversible encephalopathy syndrome: what's certain, what's new?","volume":"11","author":"Roth","year":"2011","journal-title":"Pract Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"ANJR Am Neuroradiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00134-006-0459-0","article-title":"Posterior-reversible encephalopathy syndrome in intensive care medecine","volume":"33","author":"Servillo","year":"2007","journal-title":"Intensive Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","article-title":"Posterior reversible encephalopathy syndrome-Insight into pathogenesis, clinical variants and treatment approaches","volume":"14","author":"Granata","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1007\/s12035-019-1553-y","article-title":"Arginine vasopressin and posterior reversible encephalopathy syndrome pathophysiology: the missing link?","volume":"56","author":"Largeau","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2169\/internalmedicine.42.750","article-title":"Posterior encephalopathy subsequent to cyclosporin. A presenting as irreversible abulia","volume":"42","author":"Nishie","year":"2003","journal-title":"Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1212\/01.WNL.0000138568.60774.E4","article-title":"Tacrolimus leukoencephalopathy: a neuropathologic confirmation","volume":"63","author":"Lavigne","year":"2004","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3109\/10428194.2011.638070","article-title":"Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide","volume":"53","author":"Chow","year":"2012","journal-title":"Leuk Lymphoma."},{"key":"B10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ajh.20772","article-title":"Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabin chemotherapy in a patient with acute myeloid leukemia","volume":"82","author":"Saito","year":"2007","journal-title":"Am J Hematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1080\/10428190500234424","article-title":"Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma","volume":"46","author":"Abali","year":"2005","journal-title":"Leuk Lymphoma."},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5692\/clinicalneurol.52.251","article-title":"Late onset leukoencephalopathy induced by long term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer","volume":"52","author":"Yasaki","year":"2012","journal-title":"Rinsho Shinkeigazu."},{"key":"B13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3816\/CCC.2009.n.026","article-title":"Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin","volume":"8","author":"Sharief","year":"2009","journal-title":"Clin Colorectal Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e15691","DOI":"10.1097\/MD.0000000000015691","article-title":"Chemotherapy-induced posterior reversible encephalopathy syndrome","volume":"98","author":"Cacho-Diaz","year":"2019","journal-title":"Medicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"20170033","DOI":"10.1259\/bjrcr.20170033","article-title":"Posterior encephalopathy syndrome while receiving irinotecan with fluorouracil and folinic acid for metasatic gastric cancer","volume":"4","author":"Abughanimeh","year":"2017","journal-title":"BJR Case Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3892\/ol.2015.4059","article-title":"Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: a case report and litterature review","volume":"11","author":"Xie","year":"2016","journal-title":"Oncol Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.2169\/internalmedicine.0284-17","article-title":"Posterior reversible encephalopathy syndrome after a variety of combined chemotherapies containing","volume":"57","author":"Katada","year":"2018","journal-title":"Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"391256","DOI":"10.1155\/2014\/391256","article-title":"Atypical reversible leucoencephalopathy syndrome after bevacizumab\/folfox regimen for metastatic colon cancer","volume":"2014","author":"Salmi","year":"2014","journal-title":"Case Rep Oncol Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"306983","DOI":"10.1155\/2013\/306983","article-title":"Posterior reversible encephalopathy syndrome associated with FOLFOX chemotherapy","volume":"2013","author":"Porcello Marrone","year":"2013","journal-title":"Case Rep Oncol Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1634\/theoncologist.2014-0149","article-title":"Posterior reversible encephalopathy syndrome in patients with cancer","volume":"20","author":"Singer","year":"2015","journal-title":"Oncologist."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/ijc.26180","article-title":"Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel","volume":"130","author":"Homann","year":"2012","journal-title":"Int J Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/bjc.2012.588","article-title":"Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Br J Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.mehy.2014.02.022","article-title":"Posterior reversible encephalopathy syndrome: the endothelial hypotheses","volume":"82","author":"Marra","year":"2014","journal-title":"Med Hypotheses."},{"key":"B24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/NRL.0000000000000105","article-title":"Chemotherapy-associated posterior reversible encephalopathy syndrome: a case report and review of the literature","volume":"21","author":"How","year":"2016","journal-title":"Neurologist"},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","article-title":"The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: The retrospective Berlin PRES study","volume":"259","author":"Liman","year":"2012","journal-title":"J Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jocn.2009.05.012","article-title":"Extended use dexamethasone-associated posterior reversible encephalopathy syndrome with cisplatin-based chemotherapy","volume":"16","author":"Nguyen","year":"2009","journal-title":"J Clin Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2214\/ajr.165.3.7645483","article-title":"Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy:CT and MR findingin 16 cases","volume":"165","author":"Schwartz","year":"1995","journal-title":"Am J Neuroradiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archneur.1970.00480260061008","article-title":"Biochemical basis of fluorouracil neurotoxicity. The role of krebs cycle inhibition by fluoroacetate","volume":"23","author":"Koenig","year":"1970","journal-title":"Arch Neurol."},{"key":"B29","first-page":"180","article-title":"Thiamine status in cancer patients and the effect of 5-fluorouracil therapy","volume":"38","author":"Soukop","year":"1978","journal-title":"Eur J Cancer."},{"key":"B30","first-page":"1969","article-title":"5FUand oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients","volume":"24","author":"Reerink","year":"2004","journal-title":"Anticancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1743-7563.2009.01229.x","article-title":"Reversible encephalopathy following 5-?uoruracil based chemotherapy in patients with dihydropyrimidine dehydrogenase deficiency","volume":"5","author":"Kim","year":"2009","journal-title":"Asia Pac J Clin Oncol."},{"key":"B32","first-page":"1199","article-title":"Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions","volume":"21","author":"Casey","year":"2000","journal-title":"AJNR Am J Neuroradiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archneur.64.5.746","article-title":"Linezolid-induced posterior reversible leukoencephalopathy syndrome","volume":"64","author":"Nagel","year":"2007","journal-title":"Arch Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/omcr\/omw038","article-title":"An unusual case of posterior reversible encephalopathy syndrome in a patient being weaned from intrathecal morphine","volume":"9","author":"Van Aalst","year":"2016","journal-title":"Int Med Case Rep J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/pcn.12033","article-title":"Acute alcohol withdrawal accompanied by posterior reversible encephalopathy syndrome","volume":"67","author":"Ishikawa","year":"2013","journal-title":"Psychiatry Clin Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00540-011-1256-7","article-title":"A case of posterior reversible encephalopathy syndrome after emergence from anesthesia","volume":"26","author":"Inoue","year":"2012","journal-title":"J Anesth."},{"key":"B37","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fneur.2019.00430","article-title":"Neurological involvement in primary systemic vasculitis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jns.2017.06.044","article-title":"Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome","volume":"380","author":"Parikh","year":"2017","journal-title":"J Neurol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000339253","article-title":"Posterior reversible encephalopathy syndrome during recovery from acute kidney injury after hepatitis A infection","volume":"2","author":"Kim","year":"2012","journal-title":"Case Rep Nephrol Urol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1445-5994.2004.00750.x","article-title":"Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed","volume":"35","author":"Stott","year":"2005","journal-title":"Intern Med J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00127893-200201000-00003","article-title":"Hyperpefusion encephalopathies: hypertensive encephalopathy and related conditions","volume":"8","author":"Schwartz","year":"2002","journal-title":"Neurologist."},{"key":"B43","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.reaurg.2007.09.021","article-title":"La leukoenc\u00e9phalopathie post\u00e9rieure r\u00e9versible","volume":"16","author":"Mohebbi Amoli","year":"2007","journal-title":"R\u00e9animation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"Fugate","year":"2010","journal-title":"Mayo Clin Proc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neurol.2016.06.004","article-title":"Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: a frequent association?","volume":"172","author":"Chardain","year":"2016","journal-title":"Rev Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3174\/ajnr.A4379","article-title":"Cytotoxic edema in posterior reversible encephalopathy syndrome: correlation of MRI features with serum albumine levels","volume":"36","author":"Gao","year":"2015","journal-title":"AJNR Am J Neuroradiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3174\/ajnr.A2332","article-title":"Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients","volume":"32","author":"Pirker","year":"2011","journal-title":"AJNR Am J Neuroradiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jocn.2014.03.004","article-title":"Elevation of serum lactate dehydrogenase at posterior reversible encephalopathy syndrome onset in chemotherapy-treated cancer patients","volume":"21","author":"Fitzgerald","year":"2014","journal-title":"J Clin Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1148\/radiology.219.3.r01jn48756","article-title":"Reversible posterior leuckoencephalopathy syndrome: evaluation with diffusion-tensor MR imagimg","volume":"219","author":"Mukherjee","year":"2001","journal-title":"Radiology."},{"key":"B51","first-page":"1845","article-title":"MR imaging, MR angiography, and MR spectroscopy of brain in eclampsia","volume":"18","author":"Sengar","year":"1997","journal-title":"AJNR Am J Neuroradiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00234-005-1399-z","article-title":"A brainstem variant of reversible posterior leukoencephalopathy syndrome","volume":"47","author":"Kitaguchi","year":"2005","journal-title":"Neuroradiology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00234-005-1403-7","article-title":"Reversible posterior leukoencephalopathy syndrome: a changing concept","volume":"47","author":"Bianco","year":"2005","journal-title":"Neuroradiology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.ophtha.2004.07.036","article-title":"Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature","volume":"112","author":"Kahana","year":"2005","journal-title":"Ophthalmology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejrad.2004.05.015","article-title":"Implications of postgadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome","volume":"53","author":"Ugurel","year":"2005","journal-title":"Eur J Radiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.28.9.928","article-title":"Hypertensive encephalopathy: a clinicopathologic study of 20 cases","volume":"28","author":"Chester","year":"1978","journal-title":"Neurology."},{"key":"B57","first-page":"88","article-title":"Brain microhemorrages detected on T2* weighted gradient-echo images","volume":"24","author":"Tsushima","year":"2003","journal-title":"ANJR Am J Neuroradiol."},{"key":"B58","first-page":"833","article-title":"Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome","volume":"23","author":"Eichler","year":"2002","journal-title":"AJNR Am J Neuroradiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s10067-006-0502-0","article-title":"Henoch-Schonlein purpura nephritis complicatedby reversible posterior leukoencephalopathy syndrome","volume":"26","author":"Sasayama","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/ndt\/gfg347","article-title":"Reversible posterior leukoencephalopathy in a patient with systemic sclerosis\/systemic lupus erythematosus overlap syndrome","volume":"18","author":"Yong","year":"2003","journal-title":"Nephrol Dial Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/STROKEAHA.111.626184","article-title":"Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results","volume":"43","author":"Mandell","year":"2012","journal-title":"Stroke."},{"key":"B62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000135649","article-title":"Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis","volume":"26","author":"K\u00fcker","year":"2008","journal-title":"Cerebrovasc Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1212\/01.wnl.0000342470.69739.b3","article-title":"Intracranial arterial wall imaging using highresolution 3-tesla contrast-enhanced MRI","volume":"72","author":"Swartz","year":"2009","journal-title":"Neurology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2006.10.013","article-title":"Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials","volume":"49","author":"Landoni","year":"2007","journal-title":"Am J Kidney Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00415-016-8328-4","article-title":"Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study","volume":"264","author":"Siebert","year":"2017","journal-title":"J Neurol."},{"key":"B66","first-page":"415","article-title":"Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome","volume":"19","author":"Ito","year":"1998","journal-title":"AJNR Am J Neuroradiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00415-013-6866-6","article-title":"Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with bevacizumab, gemcitabine and cisplatin","volume":"260","author":"Dersch","year":"2013","journal-title":"J Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/1752-1947-6-409","article-title":"Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: A case report","volume":"6","author":"Zahir","year":"2012","journal-title":"J Med Case Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4143\/crt.2009.41.1.53","article-title":"A case of gemcitabine and cispaltin associated posterior reversible encephalopathy syndrome","volume":"41","author":"Kwon","year":"2009","journal-title":"Cancer Res Treat."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA."},{"key":"B71","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jcrc.2011.06.014","article-title":"Critically ill patients with cancer and sepsis: clinical course and pronostic factors","volume":"27","author":"Rosolem","year":"2012","journal-title":"J Crit Care."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T04:46:19Z","timestamp":1580359579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":71,"alternative-id":["10.3389\/fneur.2019.01405"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01405","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"article-number":"1405"}}